Janus Henderson Global Life Sciences Fund (JAGLX) ist ein börsennotiertes Unternehmen im Finanzdienstleistungen Sektor, tätig in der Asset Management - Global Branche. Der Hauptsitz des Unternehmens ist in Denver, CO, United States.
JAGLX hat IPO-Datum 1998-12-31, gelistet an der NASDAQ, eine Marktkapitalisierung von $5.71B.
The Janus Henderson Global Life Sciences Fund invests at least 80% of its net assets in securities of companies with a life science orientation, pursuing growth opportunities within the global life sciences industry. The fund maintains a fundamental policy to allocate at least 25% of its total assets specifically to companies categorized in the "life sciences" sector. Through this focused investment strategy, the fund seeks to capture growth from companies operating across pharmaceutical, biotechnology, medical devices, and related life science disciplines. The portfolio manager actively identifies and selects securities of companies demonstrating strong life science fundamentals and market positioning. This concentrated approach allows the fund to build meaningful exposure to the dynamic and innovation-driven life sciences market.
